Clinical Trial Update: The Effectiveness of Silver Alginate (Algidex) Patch in the Prevention of Central Line Infections in Very Low Birth Weight Infants [NA]

View source ↗

Summary

This entry reports a completed clinical trial assessing the effectiveness of the silver alginate patch Algidex in preventing central line-associated bloodstream…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Line-associated Bloodstream Infection

Drugs mentioned

• Algidex (silver alginate patch)

Snippet

Sponsor: Baylor Research Institute | Conditions: Central Line Bloodstream Infections | NA | Status: COMPLETED